Smith & Nephew (NYSE:SNN) Sees Unusually-High Trading Volume - Still a Buy?

Smith & Nephew plc (NYSE:SNN - Get Free Report) shares saw strong trading volume on Friday . 796,808 shares traded hands during trading, an increase of 18% from the previous session's volume of 672,756 shares.The stock last traded at $24.39 and had previously closed at $24.40.

Analysts Set New Price Targets

Several research firms have recently weighed in on SNN. Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a "buy" rating to a "hold" rating in a report on Friday, November 1st. StockNews.com lowered shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, November 12th. Finally, Berenberg Bank downgraded Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Wednesday, November 6th.

Smith & Nephew Stock Up 0.1 %

The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The firm has a fifty day simple moving average of $25.38 and a 200-day simple moving average of $27.78. The firm has a market cap of $10.68 billion, a price-to-earnings ratio of 12.46, a P/E/G ratio of 1.41 and a beta of 0.84.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Allspring Global Investments Holdings LLC raised its position in shares of Smith & Nephew by 1,894.3% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider's stock valued at $43,000 after buying an additional 1,648 shares in the last quarter. Natixis Advisors LLC raised its position in Smith & Nephew by 12.0% during the second quarter. Natixis Advisors LLC now owns 78,668 shares of the medical equipment provider's stock valued at $1,949,000 after purchasing an additional 8,420 shares in the last quarter. Rhumbline Advisers lifted its stake in Smith & Nephew by 8.6% during the second quarter. Rhumbline Advisers now owns 10,365 shares of the medical equipment provider's stock worth $257,000 after purchasing an additional 819 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of Smith & Nephew by 9.3% in the 2nd quarter. American Century Companies Inc. now owns 119,347 shares of the medical equipment provider's stock valued at $2,957,000 after purchasing an additional 10,156 shares in the last quarter. Finally, Equity Investment Corp increased its stake in shares of Smith & Nephew by 27.3% in the 2nd quarter. Equity Investment Corp now owns 14,921 shares of the medical equipment provider's stock valued at $370,000 after purchasing an additional 3,200 shares during the last quarter. 25.64% of the stock is owned by institutional investors.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.